1,7-phenanthroline has been researched along with Leukemia, T-Cell in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chiang, NY; Fendly, BM; Fok, KS; Sussman, HH; Wada, HG | 1 |
Bushkin, Y; Demaria, S; Gottesman, SR; Schwab, R | 1 |
2 other study(ies) available for 1,7-phenanthroline and Leukemia, T-Cell
Article | Year |
---|---|
Activation of TNF-R1 receptor in the presence of copper kills TNF resistant CEM leukemic T cells.
Topics: Animals; Cell Line; Cell Survival; Copper; Drug Synergism; Flow Cytometry; Hydrogen-Ion Concentration; Leukemia, T-Cell; Metals; Oxidation-Reduction; Phenanthrolines; Quinacrine; Rats; Reactive Oxygen Species; Receptor Aggregation; Receptors, Tumor Necrosis Factor; Signal Transduction; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 1994 |
Soluble beta 2-microglobulin-free class I heavy chains are released from the surface of activated and leukemia cells by a metalloprotease.
Topics: Antigens, CD; Antigens, Differentiation, B-Lymphocyte; beta 2-Microglobulin; CD4 Antigens; Flow Cytometry; Histocompatibility Antigens Class I; HLA-DR Antigens; Humans; Leukemia, B-Cell; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, T-Cell; Macromolecular Substances; Metalloendopeptidases; Phenanthrolines; Receptors, Transferrin; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured; Zinc | 1994 |